Glyoxalase I A111E,paraoxonase 1 Q192R and L55M polymorphisms: susceptibility factors of multiple sclerosis?

Abstract

Multiple sclerosis (MS) is characterized by chronic inflammation and demyelination of the central nervous system (CNS). Accumulating data indicate that oxidative stress, leading to reactive oxygen species (ROS) production and lipid peroxidation, as well as elevated levels of advanced glycation end products (AGE) in CNS neurons, might play a pivotal role in the pathogenesis of a number of diseases with a neurodegenerative aspect, such as MS. Therefore, polymorphisms of genes encoding endogenous free-radical scavenging systems, such as paraoxonase 1 (PON1), and anti-glycation defences, such as glyoxalase I (GI), could influence susceptibility to MS. In the present study, we have undertaken a case-control study to investigate the possible association of GI A111E, PON1 Q192R and L55M polymorphisms with the risk of MS. The three polymorphisms were characterized in 209 patients with relapsing-remitting MS (RRMS) and in 213 healthy controls by PCR/RFLP methods using DNA from lymphocytes. We found that individuals with the GI/AE-EE genotypes and PON55/LM-MM genotypes had a significantly higher risk of MS compared with the other genotypes. The two polymorphisms appear to be common genetic traits that are associated with an increased risk for MS - the analysis of both, in each single case, may be a revealing predictable factor for MS risk. Multiple Sclerosis 2007; 13: 446-453. http://msj.sagepub.com

Keywords

glyoxalase I (GI)lipid peroxidation malondialdehyde (MDA)methylglyoxal (MG)multiple sclerosis (MS)neurodegenerative diseases paraoxonase (PON1)polymorphisms

References

Martin R. , McFarland HF , McFarlin DE Immunological aspects ofl demyelinating diseases . Annu Rev Immunol 1992; 10: 153-87 .

Steinman L. Multiple sclerosis: a co-ordinated attack against myelin in the central nervous system . Cell 1996; 85: 299-302 .

Martino G. , Adorini L. , Rieckmann P. , Hillert J. , Kallmann B. , Comi G. et al. Inflammation in multiple sclerosis: the good, the bad, and the complex . Lancet Neurol 2002; 1: 499-509 .

Sadovnick AD , Dircks A. , Ebers GC Genetic counselling in multiple sclerosis: risk to sibs and children ofl aflflected individuals . Clin Genet 1999; 56: 118-22 .

Chataway J. , Feakes R. , Coraddu F. , Gray J. , Deans J. , Fraser M. et al. The genetics ofl multiple sclerosis: principles, background and updated results ofl the United Kingdom systematic genome screen . Brain 1998; 121: 1869-87 .

Sawcer S. , Maranian M. , Setakis E. , Curwen V. , Akesson E. , Hensiek A. et al. A whole genome screen flor linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility . Brain 2002; 125: 1337-47 .

The Transatlantic Multiple Sclerosis Genetics Cooperative. A meta-analysis ofl genomic screens in multiple sclerosis . Mult Scler 2001; 7: 3-11 .

Sadovnick AD , Armstrong H. , Rice GP , Bulman D. , Hashimoto L. , Paty DW et al. A population-based study ofl multiple sclerosis in twins: update . Ann Neurol 1993 ; 33: 281-85 .

Greco A. , Minghetti I. , Sette G. , Fieschi C. , Levi G. Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis . Neurology 1999; 53: 1876-79 .

10.

Gilgun-Sherki Y. , Melamed E. , Offen D. The role ofl oxidative stress in the pathogenesis ofl multiple sclerosis: the need flor eflflective antioxidant therapy . J Neurol 2004; 251: 261-68 .

11.

Mickel HS Multiple sclerosis: a new hypothesis . Perspect Biol Med 1975; 18: 363-74 .

12.

Lassmann H. Axonal injury in multiple sclerosis . J Neurol NeurosurgPsychiatry 2003; 74: 695-97 .

13.

Sevanian A. , Hochstein P. Mechanisms and consequences ofl lipid peroxidation in biological systems . Annu Rev Nutr 1985; 5: 365-90 .

14.

Augustin W. , Wiswedel I. , Noack H. , Reinheckel T. , Reichelt O. Role ofl endogenous and exogenous antioxidants in the deflence against flunctional damage and lipid peroxidation in rat liver mitochondria . Mol Cell Biochem 1997; 174: 199-205 .

15.

Vladimirova O. , O'Connor J. , Cahill A. , Alder H. , Butunoi C. , Kalman B. Oxidative damage to DNA in plaques ofl MS brains . Mult Scler 1998; 4: 413-18 .

16.

Lu FM , Selak M. , O'Connor J. , Croul S. , Lorenzana C. , Butunoi C. et al. Oxidative damage to mitochondrial DNA and activity ofl mitochondrial enzymes in chronic active lesions ofl multiple sclerosis . J Neurol Sci 2000; 177: 95-103 .

17.

Vladimirova O. , Lu FM , Shawver L. , Kalman B. The activation ofl protein kinase C induces higher production ofl reactive oxygen species by mononuclear cells in patients with multiple sclerosis than in controls . Inflamm Res 1999; 48: 412-16 .

18.

Hunter MI , Nlemadin BC , Davidson DL Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid flrom multiple sclerosis patients . Neurochem Res 1985; 10: 1645-52 .

19.

Calabrese V. , Raggaele R. , Cosentino E. , Rizza V. Changes in cerebrospinal fluid levels ofl malondialdehyde and glutathione reductase activity in multiple sclerosis . Int J Clin Pharmacol Res 1994; 14: 119-23 .

20.

Khula B. , Luth HJ , Haferburg D. , Boeck K. , Arendt T. , Munch G. Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease . Ann NY Acad Sci 2005; 1043: 211-16 .

21.

Castellani R. , Smith MA , Richey PL , Perry G. Glycoxidation and oxidative stress in Parkinson disease and diflfluse Lewy body disease . Brain Res 1996; 737: 195-200 .

22.

Chou SM , Wang HS , Taniguchi A. , Bucala R. Advanced glycation endproducts in neurofilament conglomeration ofl motoneurons in flamilial and sporadic amyotrophic lateral sclerosis . Mol Med 1998; 4: 324-32 .

23.

Thornalley PJ Glutathione-dependent detoxification ofl α-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliflerative activity ofl glyoxalase I inhibitors . Chem Biol Interact 1998; 111: 137-51 .

24.

Takeuchi M. , Bucala R. , Suzuki T. , Ohkubo T. , Yamazaki M. , Koike T. et al. Neurotoxicity ofl advanced glycation end-products flor cultured cortical neurons . J Neuropathol Exp Neurol 2000; 59: 1094-105 .

25.

Thornalley PJ Glyoxalase I-structure, flunction and a critical role in the enzymatic deflence against glycation . Biochem Soc Trans 2003; 31: 1343-48 .

26.

Thornalley PJ The glyoxalase system: new developments towards flunctional characterization ofl a metabolic pathway flundamental to biological lifle . Biochem J 1990; 269: 1-11 .

27.

Agadjanyan ZS , Dmitriev LF , Dugin SF A new role ofl phosphoglucose isomerase. Involvement ofl the glycolytic enzyme in aldheyde metabolism . Biochem J 2005; (in press).

28.

Munch G. , Schicktanz D. , Behme A. , Gerlach M. , Riederer P. , Palm D. et al. Amino acid specificity ofl glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library . Nat Biotechnol 1999; 17: 1006-10 .

29.

Amicarelli F. , Colafarina S. , Cattani F. , Cimini A. , Di Ilio C. , Ceru MP et al. Scavenging system eflficiency is crucial flor cell resistance to ROS-mediated methylglyoxal injury . Free Radic Biol Med 2003; 35: 856-71 .

30.

Du J. , Suzuki H. , Nagase F. , Akhand AA , Ma X. , Yokoyama T. et al. Superoxide-mediated early oxidation and activation ofl ASK1 are important flor initiating methylglyoxal-induced apoptosis process . Free Radic Biol Med 2001; 31: 469-78 .

31.

Liu BF , Miyata S. , Hirota Y. , Higo S. , Miyazaki H. , Fukunaga M. et al. Methylglyoxal induces apoptosis through activation ofl p38 mitogen-activated protein kinase in rat mesangial cells . Kidney Int 2003; 63: 947-57 .

32.

Shukla Vks , Jensen GE , Clausen J. Erythrocyte glutathione peroxidase deficiency in multiple sclerosis . Acta Neurol Scand 1977; 56: 542-50 .

33.

Jensen GE , Clausen J. Glutathione peroxidase and reductase, glucose-6-phosphate dehydrogenase and catalase activities in multiple sclerosis . J Neurol Sci 1984; 63: 45-53 .

34.

Junaid MA , Kowal D. , Barua M. , Pullarkat PS , Brooks SS , Pullarkat RK Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility flactor . Am J Med Genet 2004; 131: 11-17 .

35.

Newcombe J. , Li H. , Cuzner ML Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications flor pathogenesis . Neuropathol Appl Neurobiol 1994; 20: 152-62 .

36.

Keller JN , Hanni KB , Kindy MS Oxidized high density lipoprotein induces neuron death . Exp Neurol 2000; 161: 621-30 .

37.

Bassett CN , Montine KS , Neely MD , Swift LL , Montine TJ Cerebrospinal fluid lipoproteins in Alzheimer's disease . Microsc Res Tech 2000; 50: 282-86 .

38.

Schippling S. , Kontush A. , Arlt S. , Buhmann C. , Sturenburg HJ , Mann U. et al. Increased lipoprotein oxidation in Alzheimer's disease . Free Radic Biol Med 2000 ; 28: 351-60 .

39.

La Du BN. Human serum paraoxonase/arylesterase. In Kalow W ed. Pharmacogenetics of drugs metabolism . Pergamon Press , 1992: 51-91.

40.

Mackness B. , Durrington PN , Mackness MI The paraoxonase gene flamily and coronary heart disease . Curr Opin Lipidol 2002; 13: 357-62 .

41.

Mackness MI , Mackness B. , Durrington PN , Connelly PW , Hegele RA Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins . Curr Opin Lipidol 1996; 7: 69-76 .

42.

Li HL , Liu DP , Liang CC Paraoxonase gene polymorphisms, oxidative stress, and diseases . J Mol Med 2003; 81: 766-79 .

43.

Jaouad L. , Milochevitch C. , Khalil A. PON1 paraoxonase activity is reduced during HDl oxidation and is an indicator ofl HDL antioxidant capacity . Free Radic Res 2003; 37: 77-83 .

44.

Ferretti G. , Bacchetti T. , Busni D. , Rabini RA , Curatola G. Protective eflflect ofl paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients . J Clin Endocrinol Metab 2004; 89: 2957-62 .

45.

Ferretti G. , Bacchetti T. , Marchionni C. , Caldarelli L. , Curatola G. Eflflect ofl glycation ofl high density lipoproteins on their physicochemical properties and on paraoxonase activity . Acta Diabetol 2001; 38: 163-69 .

46.

Traverso N. , Menini S. , Maineri EP , Patriarca S. , Odetti P. , Cottalasso D. et al. Malondialdehyde, a lipoperoxidation-derived aldehyde, can bring about secondary oxidative damage to proteins. Gerontol A Biol Sci Med Sci 2004 ; 59: B890-95 .

47.

Humbert R. , Alder DA , Disteche CM , Hassett C. , Omiecinski CJ , Furlong CE The molecular basis ofl the human serum paraoxonase activity polymorphism . Nat Genet 1993; 3: 73-76 .

48.

Akhmedova SN , Yakimovsky AK , Schwartz EI Paraoxonase 1 Met-Leu54 polymorphism is associated with Parkinson's disease . J Neurol Sci 2001 ; 184: 179-82 .

49.

Zintzaras E. , Hadjigeorgiou GM York Association ofl paraoxonase 1 gene polymorphisms with risk ofl Parkinson's disease . J Hum Genet 2004; 49: 474-81 .

50.

Poser CM , Paty DW , Scheinberg L. , McDonald WI , Davis FA , Ebers GC et al. New diagnostic criteria flor multiple sclerosis: guidelines flor research protocols . Ann Neurol 1983; 13: 227-31 .

51.

Tafti M. , Petit B. , Chollet D. , Neidhart E. , de Bilbao F. , Kiss JZ et al. Deficiency in short-chain flatty acid beta-oxidation aflflects theta oscillation during sleep . Nat Genet 2003; 34: 320-25 .

52.

Stafforini DM , Kushner JP , Burnham BF The eflflect ofl glyoxalase I on the metabolism ofl 4,5-dioxovaleric acid . Biochim Biophys Acta 1985; 839: 191-98 .

53.

Gardemann A. , Philipp M. , Heb K. , Katz N. , Tillmanns H. , Haberbosch W. The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk ofl coronary heart disease . Atherosclerosis 2000; 152: 421-31 .

54.

Ferrè N. , Camps J. , Fernandez-Ballart J. , Arija V. , Murphy MH , Cerveco S. et al. Regulation ofl serum paraoxonase activity by genetic, nutritional and lifle style flactors in the general population . Clin Chem 2003; 49: 1491-97 .

55.

Sidoti A. , Robledo R. , Rinaldi A. , D'Angelo R. , Rinaldi C. , Amato A. Further data on a 9.1 kb insertion/deletion polymorphism: a survey on mediterranean populations . Hum Biol (in press).